| International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials AM Orbai, M De Wit, P Mease, JA Shea, L Gossec, YY Leung, W Tillett, ... Annals of the rheumatic diseases 76 (4), 673-680, 2017 | 300 | 2017 |
| Psoriatic arthritis O FitzGerald, A Ogdie, V Chandran, LC Coates, A Kavanaugh, W Tillett, ... Nature reviews Disease primers 7 (1), 59, 2021 | 248 | 2021 |
| Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA 2 PJ Mease, A Lertratanakul, JK Anderson, K Papp, F Van den Bosch, ... Annals of the rheumatic diseases 80 (3), 312-320, 2021 | 244 | 2021 |
| Smoking and delay to diagnosis are associated with poorer functional outcome in psoriatic arthritis W Tillett, D Jadon, G Shaddick, C Cavill, E Korendowych, CS De Vries, ... Annals of the rheumatic diseases 72 (8), 1358-1361, 2013 | 207 | 2013 |
| The ClASsification for Psoriatic ARthritis (CASPAR) criteria–a retrospective feasibility, sensitivity, and specificity study W Tillett, L Costa, D Jadon, D Wallis, C Cavill, J McHUGH, ... The Journal of rheumatology 39 (1), 154-156, 2012 | 195 | 2012 |
| Work disability in psoriatic arthritis: a systematic review W Tillett, C de-Vries, NJ McHugh Rheumatology 51 (2), 275-283, 2012 | 155 | 2012 |
| Updating the psoriatic arthritis (PsA) core domain set: a report from the PsA workshop at OMERACT 2016 AM Orbai, M De Wit, PJ Mease, KC Duffin, M Elmamoun, W Tillett, ... The Journal of rheumatology 44 (10), 1522-1528, 2017 | 133 | 2017 |
| Interval between onset of psoriasis and psoriatic arthritis comparing the UK Clinical Practice Research Datalink with a hospital-based cohort W Tillett, R Charlton, A Nightingale, J Snowball, A Green, C Smith, ... Rheumatology 56 (12), 2109-2113, 2017 | 108 | 2017 |
| Group for research and assessment of psoriasis and Psoriatic arthritis/outcome measures in rheumatology consensus‐based recommendations and research agenda for use of composite … LC Coates, O FitzGerald, JF Merola, J Smolen, LJJ van Mens, ... Arthritis & rheumatology 70 (3), 345-355, 2018 | 105 | 2018 |
| Factors influencing work disability in psoriatic arthritis: first results from a large UK multicentre study W Tillett, G Shaddick, A Askari, A Cooper, P Creamer, G Clunie, ... Rheumatology 54 (1), 157-162, 2015 | 101 | 2015 |
| Modifiable risk factors and the development of psoriatic arthritis in people with psoriasis A Green, G Shaddick, R Charlton, J Snowball, A Nightingale, C Smith, ... British Journal of Dermatology 182 (3), 714-720, 2020 | 83 | 2020 |
| Upadacitinib in patients with psoriatic arthritis and inadequate response to biologics: 56-week data from the randomized controlled phase 3 SELECT-PsA 2 study PJ Mease, A Lertratanakul, KA Papp, FE van den Bosch, S Tsuji, ... Rheumatology and therapy 8 (2), 903-919, 2021 | 75 | 2021 |
| A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: a GRAPPA-OMERACT initiative P Højgaard, L Klokker, AM Orbai, K Holmsted, EM Bartels, YY Leung, ... Seminars in arthritis and rheumatism 47 (5), 654-665, 2018 | 72 | 2018 |
| Risk of uveitis and inflammatory bowel disease in people with psoriatic arthritis: a population-based cohort study R Charlton, A Green, G Shaddick, J Snowball, A Nightingale, W Tillett, ... Annals of the rheumatic diseases 77 (2), 277-280, 2018 | 69 | 2018 |
| Important treatment outcomes for patients with psoriatic arthritis: a multisite qualitative study E Dures, S Hewlett, J Lord, C Bowen, N McHugh, PROMPT Study Group, ... The Patient-Patient-Centered Outcomes Research 10, 455-462, 2017 | 67 | 2017 |
| PsAID12 provisionally endorsed at OMERACT 2018 as core outcome measure to assess psoriatic arthritis-specific health-related quality of life in clinical trials AM Orbai, R Holland, YY Leung, W Tillett, N Goel, R Christensen, ... The Journal of rheumatology 46 (8), 990-995, 2019 | 62 | 2019 |
| Exploring ankylosing spondylitis-associated ERAP1, IL23R and IL12B gene polymorphisms in subphenotypes of psoriatic arthritis D Jadon, W Tillett, D Wallis, C Cavill, J Bowes, N Waldron, A Dixon, ... Rheumatology 52 (2), 261-266, 2013 | 59 | 2013 |
| Validation of the Psoriatic Arthritis Impact of Disease (PsAID) Questionnaire and its potential as a single-item outcome measure in clinical practice R Holland, W Tillett, E Korendowych, C Cavill, N Waldron, M Brooke, ... Annals of the rheumatic diseases 77 (3), 343-347, 2018 | 58 | 2018 |
| Endorsement of the 66/68 joint count for the measurement of musculoskeletal disease activity: OMERACT 2018 psoriatic arthritis workshop report A Duarte-García, YY Leung, LC Coates, D Beaton, R Christensen, ... The Journal of rheumatology 46 (8), 996-1005, 2019 | 57 | 2019 |
| Defining outcome measures for psoriatic arthritis: a report from the GRAPPA-OMERACT working group A Ogdie, M De Wit, KC Duffin, W Campbell, J Chau, LC Coates, L Eder, ... The Journal of rheumatology 44 (5), 697-700, 2017 | 56 | 2017 |
Gavin ShaddickPVC, Head of College of Physical Sciences and EngineeringVerifisert e-postadresse på cardiff.ac.uk